St. Louis, MO (PRWEB) February 19, 2015
Attorneys representing clients in Xarelto lawsuits as part of Xarelto (Rivaroxaban) Products Liability Litigation (MDL No. 2592) for the Onder Law Firm announce the appointment of counsel to the Plaintiffs' Steering Committee. According to a recent court document, Pretrial Order #7, the Plaintiffs' Steering Committee was appointed on February 9, 2015.
From the group of applicants, the Court selected the following members, according to court documents: Andy Birchfield of Montgomery, Alabama; Brian Barr of Pensacola, Florida; Russell Abney of Atlanta, Georgia; Mark Alan Hoffman of Philadelphia, Pennsylvania; Bradley Honnold of Leawood, Kansas; Frederick Longer of Philadelphia, Pennsylvania; Sindhu Daniel of Newark, New Jersey; Dianne Nast of Philadelphia, Pennsylvania; Roger Denton of St. Louis, Missouri; Neil Overholtz of Pensacola, Florida; Michael Goetz of Tampa, Florida; and Ellen Relkin of New York, New York. Birchfield and Barr have been appointed Co-Lead Counsel, according to the court documents. Additionally, Leonard Davis and Gerald Meunier are set as the Co-Plaintiffs’ Liaison Counsel. Each of these appointments is for one year, according to the Pretrial Order.
The Co-Plaintiffs’ Liaisons and the Co-Lead Counsel together comprise the Plaintiffs’ Steering Executive Committee, who are charged with coordinating the Steering Committee, scheduling meetings, keeping minutes, attending status conferences, and other administrative functions, according to the court document. The appointment of the Plaintiffs’ Steering Committee is a routine early pretrial proceeding, which allows for Discovery to commence, according to the Onder Law Firm.
Attorneys representing clients nationwide in Xarelto lawsuits are still accepting Xarelto claims for possible inclusion in the MDL. Xarelto lawsuits were consolidated in Louisiana during December of 2014 under the name Xarelto (Rivaroxaban) Products Liability Litigation (MDL No. 2592), according to court documents from the Judicial Panel on Multidistrict Litigation. Plaintiffs in Xarelto lawsuits allege that the Xarelto’s label did not adequately warn consumers of the potential for serious side effects such as internal bleeding, according to court documents.
Xarelto lawyers representing clients nationwide for the Onder Law Firm are now accepting claims from individuals and families of individuals who suffered from severe internal bleeding or hemorrhagic stroke and also have a history of taking Xarelto. Lawyers are investigating these inquiries for possible Xarelto lawsuits. The Onder Law Firm is renowned for its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Individuals and the family members of individuals who have suffered from internal bleeding and have taken Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website. The firm provides information on bleeding warnings and Xarelto lawsuit news.
The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.
About The Onder Law Firm
Onder, Shelton, OLeary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, OLeary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firms Xarelto attorneys provide information to the public at http://www.XareltoContingencyLawsuit.com.